Mir-302 suppresses the proliferation, migration, and invasion of breast cancer cells by downregulating atad2

HIGHLIGHTS

• who: Yo Sep Hwang and collaborators from the Department of Biomolecular Science, KRIBB School of Bioscience, University of Science and have published the paper: miR-302 Suppresses the Proliferation, Migration, and Invasion of Breast Cancer Cells by Downregulating ATAD2, in the Journal: Cancers 2022, 14, 4345. of /2022/
• what: The authors provide evidence suggesting that miR-302 plays a crucial role in inhibiting cancer cell proliferation, migration, and invasion in_vitro and tumor growth in_vivo by targeting ATAD2. The authors propose that miR-302 may be a potential therapeutic candidate for breast cancer treatment.
•  

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.